Stock listing

NYSE American:APUS Apimeds Pharmaceuticals US, Inc. Stock

Home listing (NYSE American) of Apimeds Pharmaceuticals US, Inc.

Follow Apimeds Pharmaceuticals US, Inc. into a list and get an email when it puts out news.

Share price · AMEX:APUS

$2.89 USD -0.12 (-4.0%)

Close on Nov 2, 2026

Past year -88.3% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$2.78 – $3.02 USDNov 2, 2026
Volume
38,230 sharesNov 2, 2026
Market cap
$4.36M USDAt the close on Nov 2, 2026 · price × 1.51M shares outstanding
52-week range
$1.51 – $59.70 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$21.44M USDMedian day 66,000 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Apimeds Pharmaceuticals US, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:APUS · Home$2.89 USD-0.12 (-4.0%)38,230$3.01$3.02$2.78$3.01Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · AMEX:APUS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.89-0.12-4.0%$3.01$3.02$2.7838,230
$3.01-0.20-6.2%$3.11$3.11$2.8420,052
$3.21+0.14+4.6%$2.89$3.21$2.8348,752
$3.07+0.02+0.7%$2.39$3.095$2.3968,288
$3.05+0.155+5.4%$2.90$3.05$2.65143,086
$2.895+0.005+0.2%$2.92$3.06$2.71329,730
$2.89-0.27-8.5%$3.07$3.175$2.8135,400
$3.16-0.09-2.8%$3.14$3.25$3.0642,300
$3.25-0.16-4.7%$3.51$3.57$3.005128,000
$3.41-0.09-2.6%$3.43$3.55$3.2166,000
$3.50-0.54-13.4%$3.92$3.95$3.40101,700
$4.04-0.35-8.0%$4.16$4.35$3.9043,200
$4.39-0.19-4.1%$4.25$4.415$4.00109,000
$4.58-0.04-0.9%$4.60$4.81$4.25235,300
$4.62-0.58-11.2%$4.87$4.91$4.26339,800
$5.20+0.18+3.6%$5.43$6.036$4.9711,394,300
$5.02-0.49-8.9%$5.54$5.72$4.403,346,300
$5.51-1.54-21.8%$6.43$6.496$5.211,112,800
$7.05-0.08-1.1%$8.00$9.84$6.8622,395,400
$7.13+2.54+55.3%$4.91$8.39$4.7143,838,600
$4.59+1.37+42.5%$4.99$5.83$4.2133,787,400
$3.22-0.88-21.5%$4.10$4.16$3.10138,400
$4.10-0.90-18.0%$4.90$5.09$4.10145,800
$5.00-0.02-0.4%$5.04$5.25$4.72190,100
$5.02-1.37-21.4%$6.17$6.17$4.63762,100
$6.39-0.86-11.9%$6.33$6.50$5.56858,800
$7.25+2.33+47.4%$8.32$9.14$5.3937,114,300
$4.92+2.63+114.8%$6.99$8.74$4.6187,850,200
$2.29+0.44+23.8%$1.81$2.30$1.745152,500
$1.85+0.18+10.8%$1.65$1.999$1.613132,400
$1.67-0.10-5.6%$1.72$1.865$1.67671,000
$1.77+0.10+6.0%$1.68$2.10$1.631,335,500
$1.67+0.07+4.4%$1.73$1.92$1.6083,900
$1.60-0.04-2.4%$1.71$1.71$1.5164,300
$1.64-0.45-21.5%$2.11$2.11$1.6066,200
$2.09-0.015-0.7%$2.39$2.39$2.02529,800
$2.105-0.065-3.0%$2.16$2.26$2.0920,700
$2.17-0.12-5.2%$2.26$2.47$2.1240,600
$2.29-0.01-0.4%$2.30$2.35$2.1729,500
$2.30-0.12-5.0%$2.40$2.405$2.2517,421
$2.42-0.09-3.6%$2.49$2.60$2.4224,400
$2.51-0.12-4.6%$2.66$2.71$2.4050,600
$2.63-0.91-25.7%$3.17$3.38$2.5184,100
$3.54-0.34-8.8%$3.87$3.87$3.4129,200
$3.88+0.01+0.3%$4.09$4.09$3.738,200
$3.87-0.08-2.0%$4.10$4.10$3.8619,100
$3.95-0.65-14.1%$4.63$4.81$3.737172,200
$4.60-0.37-7.4%$4.74$4.99$4.358230,135
$4.97+0.22+4.6%$4.78$5.35$4.6549,100
$4.75-0.09-1.9%$4.34$4.75$4.3415,900
$4.84+0.45+10.3%$4.30$5.43$4.175559,500
$4.390.000.0%$4.23$4.50$4.09117,200
$4.39+0.39+9.7%$3.88$4.55$3.6923,000
$4.00-0.28-6.5%$3.99$4.30$3.8538,200
$4.28-0.27-5.9%$3.45$4.30$3.391,617,000
$4.55-0.15-3.2%$4.72$4.93$4.5521,300
$4.70+0.04+0.9%$4.37$4.99$4.3752,400
$4.66+0.03+0.6%$4.46$4.73$4.36311,300
$4.63+0.39+9.2%$4.47$4.63$4.2856,100
$4.24+0.01+0.2%$4.39$4.61$4.237,700
$4.23-0.60-12.4%$4.75$4.815$4.238,300
$4.83+0.18+3.9%$4.69$4.89$4.5476,800
$4.65-0.27-5.5%$4.77$5.155$4.6516,900
$4.92+0.07+1.4%$4.90$5.43$4.65918,600
$4.85-0.30-5.8%$5.18$5.30$4.8323,600
Ticker
NYSE American:APUS
Asset type
Stock
Exchange
NYSE American
Currency
USD

What changed lately

Latest news

All Apimeds Pharmaceuticals US, Inc. news

Decks

Apimeds Pharmaceuticals US, Inc. on 6ix

News releases
11 in the last 12 months · 19 in all · newest Sep 14, 2026 · oldest 2025
Decks
2 decks · latest July 2025

Where Apimeds Pharmaceuticals US, Inc. is listed

ListingExchangeCountryCurrency
NYSE American:APUS · Home listing · This pageNYSE AmericanUnited StatesUSD
BOATS:APUSBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Apimeds Pharmaceuticals US, Inc.